 | • レポートコード：D005-00873 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、RSV診断の世界市場を広く調査・分析し、今後の市場展望をまとめております。RSV診断の種類別市場規模（キット・アッセイ、機器、その他）、用途別市場規模（病院・診療所、臨床検査室、在宅医療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：bioMérieux、Biocartis、BD、Abbott、Danaher、Roche、Luminex、Thermo Fisher、Hologic ・地域別グローバル市場分析 2015年-2020年 ・RSV診断の北米市場（アメリカ、カナダ、メキシコ） ・RSV診断のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・RSV診断のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・RSV診断の南米市場（ブラジル、アルゼンチン） ・RSV診断の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：キット・アッセイ、機器、その他 ・用途別分析：病院・診療所、臨床検査室、在宅医療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global RSV Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 719.2 million by 2025, from USD 581 million in 2019.
The RSV Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
RSV Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, RSV Diagnostics market has been segmented into:
Kits and Assays
Instruments
Other
By Application, RSV Diagnostics has been segmented into:
Hospitals & Clinics
Clinical Laboratories
Homecare
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global RSV Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level RSV Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global RSV Diagnostics market.
The report offers in-depth assessment of the growth and other aspects of the RSV Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and RSV Diagnostics Market Share Analysis
RSV Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, RSV Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the RSV Diagnostics sales, revenue and market share for each player covered in this report.
The major players covered in RSV Diagnostics are:
bioMérieux
Biocartis
BD
Abbott
Danaher
Roche
Luminex
Thermo Fisher
Hologic
Table of Contents
1 RSV Diagnostics Market Overview
1.1 Product Overview and Scope of RSV Diagnostics
1.2 Classification of RSV Diagnostics by Type
1.2.1 Global RSV Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global RSV Diagnostics Revenue Market Share by Type in 2019
1.2.3 Kits and Assays
1.2.4 Instruments
1.2.5 Other
1.3 Global RSV Diagnostics Market by Application
1.3.1 Overview: Global RSV Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals & Clinics
1.3.3 Clinical Laboratories
1.3.4 Homecare
1.4 Global RSV Diagnostics Market by Regions
1.4.1 Global RSV Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of RSV Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) RSV Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) RSV Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) RSV Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) RSV Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) RSV Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 bioMérieux
2.1.1 bioMérieux Details
2.1.2 bioMérieux Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 bioMérieux SWOT Analysis
2.1.4 bioMérieux Product and Services
2.1.5 bioMérieux RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biocartis
2.2.1 Biocartis Details
2.2.2 Biocartis Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biocartis SWOT Analysis
2.2.4 Biocartis Product and Services
2.2.5 Biocartis RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BD SWOT Analysis
2.3.4 BD Product and Services
2.3.5 BD RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbott SWOT Analysis
2.4.4 Abbott Product and Services
2.4.5 Abbott RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Danaher
2.5.1 Danaher Details
2.5.2 Danaher Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Danaher SWOT Analysis
2.5.4 Danaher Product and Services
2.5.5 Danaher RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Luminex
2.7.1 Luminex Details
2.7.2 Luminex Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Luminex SWOT Analysis
2.7.4 Luminex Product and Services
2.7.5 Luminex RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Thermo Fisher
2.8.1 Thermo Fisher Details
2.8.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Thermo Fisher SWOT Analysis
2.8.4 Thermo Fisher Product and Services
2.8.5 Thermo Fisher RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hologic
2.9.1 Hologic Details
2.9.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hologic SWOT Analysis
2.9.4 Hologic Product and Services
2.9.5 Hologic RSV Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global RSV Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 RSV Diagnostics Players Market Share
3.2.2 Top 10 RSV Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global RSV Diagnostics Revenue and Market Share by Regions
4.2 North America RSV Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe RSV Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific RSV Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America RSV Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa RSV Diagnostics Revenue and Growth Rate (2015-2020)
5 North America RSV Diagnostics Revenue by Countries
5.1 North America RSV Diagnostics Revenue by Countries (2015-2020)
5.2 USA RSV Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada RSV Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico RSV Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe RSV Diagnostics Revenue by Countries
6.1 Europe RSV Diagnostics Revenue by Countries (2015-2020)
6.2 Germany RSV Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK RSV Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France RSV Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia RSV Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy RSV Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific RSV Diagnostics Revenue by Countries
7.1 Asia-Pacific RSV Diagnostics Revenue by Countries (2015-2020)
7.2 China RSV Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan RSV Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea RSV Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India RSV Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia RSV Diagnostics Revenue and Growth Rate (2015-2020)
8 South America RSV Diagnostics Revenue by Countries
8.1 South America RSV Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil RSV Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina RSV Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue RSV Diagnostics by Countries
9.1 Middle East & Africa RSV Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia RSV Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE RSV Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt RSV Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa RSV Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global RSV Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global RSV Diagnostics Market Forecast by Type (2019-2024)
10.3 Kits and Assays Revenue Growth Rate (2015-2025)
10.4 Instruments Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global RSV Diagnostics Market Segment by Application
11.1 Global RSV Diagnostics Revenue Market Share by Application (2015-2020)
11.2 RSV Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospitals & Clinics Revenue Growth (2015-2020)
11.4 Clinical Laboratories Revenue Growth (2015-2020)
11.5 Homecare Revenue Growth (2015-2020)
12 Global RSV Diagnostics Market Size Forecast (2021-2025)
12.1 Global RSV Diagnostics Market Size Forecast (2021-2025)
12.2 Global RSV Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America RSV Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe RSV Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific RSV Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America RSV Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa RSV Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global RSV Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of RSV Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global RSV Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market RSV Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. bioMérieux Corporate Information, Location and Competitors
Table 6. bioMérieux RSV Diagnostics Major Business
Table 7. bioMérieux RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. bioMérieux SWOT Analysis
Table 9. bioMérieux RSV Diagnostics Product and Solutions
Table 10. bioMérieux RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Biocartis Corporate Information, Location and Competitors
Table 12. Biocartis RSV Diagnostics Major Business
Table 13. Biocartis RSV Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. Biocartis SWOT Analysis
Table 15. Biocartis RSV Diagnostics Product and Solutions
Table 16. Biocartis RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. BD Corporate Information, Location and Competitors
Table 18. BD RSV Diagnostics Major Business
Table 19. BD RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. BD SWOT Analysis
Table 21. BD RSV Diagnostics Product and Solutions
Table 22. BD RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbott Corporate Information, Location and Competitors
Table 24. Abbott RSV Diagnostics Major Business
Table 25. Abbott RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Abbott SWOT Analysis
Table 27. Abbott RSV Diagnostics Product and Solutions
Table 28. Abbott RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Danaher Corporate Information, Location and Competitors
Table 30. Danaher RSV Diagnostics Major Business
Table 31. Danaher RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. Danaher SWOT Analysis
Table 33. Danaher RSV Diagnostics Product and Solutions
Table 34. Danaher RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Roche Corporate Information, Location and Competitors
Table 36. Roche RSV Diagnostics Major Business
Table 37. Roche RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. Roche SWOT Analysis
Table 39. Roche RSV Diagnostics Product and Solutions
Table 40. Roche RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Luminex Corporate Information, Location and Competitors
Table 42. Luminex RSV Diagnostics Major Business
Table 43. Luminex RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Luminex SWOT Analysis
Table 45. Luminex RSV Diagnostics Product and Solutions
Table 46. Luminex RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Thermo Fisher Corporate Information, Location and Competitors
Table 48. Thermo Fisher RSV Diagnostics Major Business
Table 49. Thermo Fisher RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 50. Thermo Fisher SWOT Analysis
Table 51. Thermo Fisher RSV Diagnostics Product and Solutions
Table 52. Thermo Fisher RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Hologic Corporate Information, Location and Competitors
Table 54. Hologic RSV Diagnostics Major Business
Table 55. Hologic RSV Diagnostics Total Revenue (USD Million) (2017-2018)
Table 56. Hologic SWOT Analysis
Table 57. Hologic RSV Diagnostics Product and Solutions
Table 58. Hologic RSV Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global RSV Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 60. Global RSV Diagnostics Revenue Share by Players (2015-2020)
Table 61. Global RSV Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 62. Global RSV Diagnostics Revenue Market Share by Regions (2015-2020)
Table 63. North America RSV Diagnostics Revenue by Countries (2015-2020)
Table 64. North America RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Table 65. Europe RSV Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific RSV Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 67. South America RSV Diagnostics Revenue by Countries (2015-2020)
Table 68. South America RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa RSV Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Table 71. Global RSV Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 72. Global RSV Diagnostics Revenue Share by Type (2015-2020)
Table 73. Global RSV Diagnostics Revenue Forecast by Type (2021-2025)
Table 74. Global RSV Diagnostics Revenue by Application (2015-2020)
Table 75. Global RSV Diagnostics Revenue Share by Application (2015-2020)
Table 76. Global RSV Diagnostics Revenue Forecast by Application (2021-2025)
Table 77. Global RSV Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. RSV Diagnostics Picture
Figure 2. Global RSV Diagnostics Revenue Market Share by Type in 2019
Figure 3. Kits and Assays Picture
Figure 4. Instruments Picture
Figure 5. Other Picture
Figure 6. RSV Diagnostics Revenue Market Share by Application in 2019
Figure 7. Hospitals & Clinics Picture
Figure 8. Clinical Laboratories Picture
Figure 9. Homecare Picture
Figure 10. Global RSV Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global RSV Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global RSV Diagnostics Revenue Share by Players in 2019
Figure 18. Global Top 5 Players RSV Diagnostics Revenue Market Share in 2019
Figure 19. Global Top 10 Players RSV Diagnostics Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global RSV Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global RSV Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 23. Global RSV Diagnostics Revenue Market Share by Regions in 2018
Figure 24. North America RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 25. Europe RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. South America RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. North America RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 30. North America RSV Diagnostics Revenue Market Share by Countries in 2019
Figure 31. USA RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 32. Canada RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Mexico RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Europe RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 35. Europe RSV Diagnostics Revenue Market Share by Countries in 2019
Figure 36. Germany RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 37. UK RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. France RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. Russia RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Italy RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific RSV Diagnostics Revenue Market Share by Countries in 2019
Figure 43. China RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 44. Japan RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Korea RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. India RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. South America RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 49. South America RSV Diagnostics Revenue Market Share by Countries in 2019
Figure 50. Brazil RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 51. Argentina RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa RSV Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa RSV Diagnostics Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 55. UAE RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. Egypt RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. South Africa RSV Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. Global RSV Diagnostics Revenue Share by Type (2015-2020)
Figure 59. Global RSV Diagnostics Revenue Share by Type in 2019
Figure 60. Global RSV Diagnostics Market Share Forecast by Type (2021-2025)
Figure 61. Global Kits and Assays Revenue Growth Rate (2015-2020)
Figure 62. Global Instruments Revenue Growth Rate (2015-2020)
Figure 63. Global Other Revenue Growth Rate (2015-2020)
Figure 64. Global RSV Diagnostics Revenue Share by Application (2015-2020)
Figure 65. Global RSV Diagnostics Revenue Share by Application in 2019
Figure 66. Global RSV Diagnostics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals & Clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Clinical Laboratories Revenue Growth Rate (2015-2020)
Figure 69. Global Homecare Revenue Growth Rate (2015-2020)
Figure 70. Global RSV Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global RSV Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global RSV Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America RSV Diagnostics Revenue Market Forecast (2021-2025)
Figure 74. Europe RSV Diagnostics Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific RSV Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. South America RSV Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa RSV Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
専門診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Professional Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Professional Diagnos…- 分子診断及びNATの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Molecular Diagnostics and NAT market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Molecular Diagn…
- 脳卒中診断＆治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Stroke Diagnostics and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 27550 million by 2025, from USD 23000 million in 2019. The St…
- 敗血症診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Sepsis Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 439.3 million by 2025, from USD 362.3 million in 2019. The Sepsis Diagnostics …
- 体外診断用医薬品（IVD）の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Vitro Diagnostics (IVD) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vitro Diagnostics (IV…